Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21001053 | 0.80 | THRA (0.31) | — | |
| SCHEMBL98092 | 0.78 | ADH1A (0.40) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL7353900 | 0.78 | ADH1A (0.40) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL3980758 | 0.77 | — | — | |
| SCHEMBL6711004 | 0.75 | IDO1 (0.30) | — | |
| SCHEMBL15973100 | 0.72 | ADH1B (0.34) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL3224228 | 0.72 | EPHX2 (0.31) | — | |
| SCHEMBL3234976 | 0.69 | ADH1B (0.36) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL12805794 | 0.69 | — | — | |
| SCHEMBL11671685 | 0.68 | EPHX1 (0.32) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101535232-B | Fragrance compound | GIVAUDAN S.A. (CH) | 2016-05-11 | — | — | CN | disclosed |
| CN-104045535-A | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES BV | 2014-09-17 | — | — | CN | disclosed |
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20140142343-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2014-05-22 | — | — | US | disclosed |
| US-8709994-B2 | Fragrance compounds | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2014-04-29 | — | — | US | disclosed |
| EP-2077986-B1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2013-12-04 | — | — | EP | disclosed |
| EP-2657218-A1 | Novel Fragrance Compounds | Givaudan Nederland Services B.V. (NL) | 2013-10-30 | — | — | EP | disclosed |
| EP-2657218-A1 | Novel Fragrance Compounds | Givaudan Nederland Services B.V. (NL) | 2013-10-30 | — | — | EP | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| CN-101535232-A | Novel fragrance compounds | QUEST INT SERV BV (NL) | 2009-09-16 | — | — | CN | disclosed |
| EP-2077986-A1 | NOVEL FRAGRANCE COMPOUNDS | Givaudan Nederland Services B.V. (NL) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069287-A1 | Novel Fragrance Compounds | C1S, C5, FADS1 | ADH1B 888/4885ADH1C 375/4885ADH1A 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.